Sally C. Pipes

Commentary

We don’t need socialism to cut drug prices. Americans get a good deal

Nearly nine in every 10 Americans say that prescription drug prices are too high. Yet the average prescription costs less in the U.S. than in other developed countries, according to a new study from professor Tomas Phillipson, the former chairman of the White House Council of Economic Advisers. That finding ...
Commentary

Medicaid At 60: A Safety Net In Need Of Serious Repair

Today, Medicaid turns 60. But this will be no diamond jubilee. What began in 1965 as a modest safety-net program has ballooned into the largest health entitlement in the country, covering nearly 80 million Americans, costing close to $900 billion a year, and delivering poor value for both patients and ...
Commentary

Doctors Deserve More Than a Token Pay ‘Raise’ from Medicare

The Trump administration is giving doctors a modest pay raise. A proposal released this month by the Centers for Medicare and Medicaid Services would, among other things, implement the 2.5% hike in Medicare physician reimbursement established by the One Big Beautiful Bill Act, which President Trump signed into law July ...
Commentary

America Doesn’t Have Enough Doctors. Medicare Is Making That Worse.

The United States is facing a shortage of 37,000 physicians, according to the latest research from the Association of American Medical Colleges. That deficit will more than double to 86,000 doctors by 2036. Medicare’s chronically low reimbursement rates deserve at least part of the blame. According to the American Medical ...
Commentary

How Price Controls Make a Healthy Drug Market Sick

The unspoken assumption behind the prescription drug price controls at the heart of the Democrats’ August 2022 Inflation Reduction Act (IRA) is that the pharmaceutical market is broken. According to this view, drugmakers have the power to charge whatever they want. Only a sweeping system of government price-setting can put ...
Commentary

Medicare Turns 60 This Month: It’s Time for an Intervention

On July 30, Medicare will mark its 60th birthday. Like many 60-year-olds, it’s in the throes of a midlife crisis. But unlike a harmless convertible purchase or spontaneous trip to Paris, this one midlife crisis threatens the nation’s fiscal health — and the well-being of future retirees. Read the entire ...
Commentary

Thank Obamacare for America’s insurance fraud boom

The number of Americans enrolled in marketplace plans either fraudulently or improperly reached 6.4 million in 2025 — an increase of more than one-quarter, according to an analysis published last month by the Paragon Health Institute. All of this wrongdoing will cost American taxpayers an estimated $27 billion this year. ...
Commentary

Feds right to curtail California’s Medicaid scam

On Independence Day, President Trump signed the One Big Beautiful Bill Act, which is projected to reduce enrollment in Medicaid programs throughout the country, including Medi-Cal in California. But Californians should cheer, not jeer, these coverage “losses.” The law will primarily disenroll people who should have never been covered by ...
Commentary

Let’s talk about medical debt

A federal judge this month tossed out a Biden-era rule that would have wiped medical debt from consumers’ credit reports. The decision is a victory for borrowers and lenders alike. The now-defunct rule could have ended up hurting the very low-income individuals it was meant to help. Read the entire ...
Commentary

Trump Must Shut Down Counterfeit Weight-Loss Drugs

Americans looking to lose weight are increasingly turning to the internet. And they’re being duped. Telehealth startups and fly-by-night pharmacies are peddling what look like cheap, convenient versions of blockbuster drugs like Ozempic and Wegovy. But many of these offerings are neither authentic nor safe. They’re “compounded” copies — knockoffs ...
Commentary

We don’t need socialism to cut drug prices. Americans get a good deal

Nearly nine in every 10 Americans say that prescription drug prices are too high. Yet the average prescription costs less in the U.S. than in other developed countries, according to a new study from professor Tomas Phillipson, the former chairman of the White House Council of Economic Advisers. That finding ...
Commentary

Medicaid At 60: A Safety Net In Need Of Serious Repair

Today, Medicaid turns 60. But this will be no diamond jubilee. What began in 1965 as a modest safety-net program has ballooned into the largest health entitlement in the country, covering nearly 80 million Americans, costing close to $900 billion a year, and delivering poor value for both patients and ...
Commentary

Doctors Deserve More Than a Token Pay ‘Raise’ from Medicare

The Trump administration is giving doctors a modest pay raise. A proposal released this month by the Centers for Medicare and Medicaid Services would, among other things, implement the 2.5% hike in Medicare physician reimbursement established by the One Big Beautiful Bill Act, which President Trump signed into law July ...
Commentary

America Doesn’t Have Enough Doctors. Medicare Is Making That Worse.

The United States is facing a shortage of 37,000 physicians, according to the latest research from the Association of American Medical Colleges. That deficit will more than double to 86,000 doctors by 2036. Medicare’s chronically low reimbursement rates deserve at least part of the blame. According to the American Medical ...
Commentary

How Price Controls Make a Healthy Drug Market Sick

The unspoken assumption behind the prescription drug price controls at the heart of the Democrats’ August 2022 Inflation Reduction Act (IRA) is that the pharmaceutical market is broken. According to this view, drugmakers have the power to charge whatever they want. Only a sweeping system of government price-setting can put ...
Commentary

Medicare Turns 60 This Month: It’s Time for an Intervention

On July 30, Medicare will mark its 60th birthday. Like many 60-year-olds, it’s in the throes of a midlife crisis. But unlike a harmless convertible purchase or spontaneous trip to Paris, this one midlife crisis threatens the nation’s fiscal health — and the well-being of future retirees. Read the entire ...
Commentary

Thank Obamacare for America’s insurance fraud boom

The number of Americans enrolled in marketplace plans either fraudulently or improperly reached 6.4 million in 2025 — an increase of more than one-quarter, according to an analysis published last month by the Paragon Health Institute. All of this wrongdoing will cost American taxpayers an estimated $27 billion this year. ...
Commentary

Feds right to curtail California’s Medicaid scam

On Independence Day, President Trump signed the One Big Beautiful Bill Act, which is projected to reduce enrollment in Medicaid programs throughout the country, including Medi-Cal in California. But Californians should cheer, not jeer, these coverage “losses.” The law will primarily disenroll people who should have never been covered by ...
Commentary

Let’s talk about medical debt

A federal judge this month tossed out a Biden-era rule that would have wiped medical debt from consumers’ credit reports. The decision is a victory for borrowers and lenders alike. The now-defunct rule could have ended up hurting the very low-income individuals it was meant to help. Read the entire ...
Commentary

Trump Must Shut Down Counterfeit Weight-Loss Drugs

Americans looking to lose weight are increasingly turning to the internet. And they’re being duped. Telehealth startups and fly-by-night pharmacies are peddling what look like cheap, convenient versions of blockbuster drugs like Ozempic and Wegovy. But many of these offerings are neither authentic nor safe. They’re “compounded” copies — knockoffs ...
Scroll to Top